A STUDY COMPARING ACTION OF BUPIVACAINE 0.5 percent V/S LEVOBUPIVACAINE 0.5 percent IN SPINAL ANAESTHESIA FOR LOWER ABDOMINAL AND LOWER EXTERMITY SURGERIES

A COMPARATIVE STUDY OF HYPERBARIC BUPIVACAINE 0.5 percent V/S HYPERBARIC LEVOBUPIVACAINE 0.5 percent IN SPINAL ANAESTHESIA FOR LOWER ABDOMINAL AND LOWER EXTERMITY SURGERIES - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080915

Enrollment

Registered

2025-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: hyperbaric bupivacaine 0.5%: patient undergoing lower abdominal and lower extremity surgeries under spinal anesthesia using 0.3mg per kg hyperbaric bupivacaine will be done or 1year Con

Eligibility

Inclusion criteria

Inclusion criteria: American society of Anaesthesiologist (ASA) physical status I/II Planned for elective surgery under Spinal anaesthesia. BMI -18.5-25

Exclusion criteria

Exclusion criteria: Patients refusing consent Patients having local sepsis at site where spinal anesthesia is to given. Patients with known bleeding or coagulation disorders Patients with spinal deformity Patients with Cardiopulmonary diseases Patients with Neurological or psychiatric disorders.

Design outcomes

Primary

Measure	Time frame
To explore the dose-response relationship between hyperbaric bupivacaine and hyperbaric levobupivaciane regarding anaesthesia quality and durationTimepoint: Every 3 min for 15 min then every 15 min till recovery	—

Secondary

Measure	Time frame
To identify any potential predictors of optimal dose selection based on individual patient factors & surgical requirementsTimepoint: Every 3 min for 15 min then every 15 min till recovery	—

Countries

India

Contacts

Public ContactDr Garima Chaurasia

Varun Arjun Medical College and Rohilkhand Hospital

RICHANSHU45@gmail.com7080470075

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026